Cargando…

P1239: BRUTON TYROSINE KINASE (BTK) PROTEIN DEGRADER BGB-16673 IS LESS APT TO CAUSE, AND ABLE TO OVERCOME VARIABLE BTK RESISTANCE MUTATIONS COMPARED TO OTHER BTK INHIBITORS (BTKI)

Detalles Bibliográficos
Autores principales: Feng, Xiaoyu, Wang, Yangyang, Long, Tao, Bai, Lanyue, Yang, Xiaojiao, Yang, Ailing, Chen, Xiangmei, Puig, Oscar, Yue, Yangbo, Shen, Zhirong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431179/
http://dx.doi.org/10.1097/01.HS9.0000971848.36885.5c
_version_ 1785091140071981056
author Feng, Xiaoyu
Wang, Yangyang
Long, Tao
Bai, Lanyue
Yang, Xiaojiao
Yang, Ailing
Chen, Xiangmei
Puig, Oscar
Yue, Yangbo
Shen, Zhirong
author_facet Feng, Xiaoyu
Wang, Yangyang
Long, Tao
Bai, Lanyue
Yang, Xiaojiao
Yang, Ailing
Chen, Xiangmei
Puig, Oscar
Yue, Yangbo
Shen, Zhirong
author_sort Feng, Xiaoyu
collection PubMed
description
format Online
Article
Text
id pubmed-10431179
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104311792023-08-17 P1239: BRUTON TYROSINE KINASE (BTK) PROTEIN DEGRADER BGB-16673 IS LESS APT TO CAUSE, AND ABLE TO OVERCOME VARIABLE BTK RESISTANCE MUTATIONS COMPARED TO OTHER BTK INHIBITORS (BTKI) Feng, Xiaoyu Wang, Yangyang Long, Tao Bai, Lanyue Yang, Xiaojiao Yang, Ailing Chen, Xiangmei Puig, Oscar Yue, Yangbo Shen, Zhirong Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431179/ http://dx.doi.org/10.1097/01.HS9.0000971848.36885.5c Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Feng, Xiaoyu
Wang, Yangyang
Long, Tao
Bai, Lanyue
Yang, Xiaojiao
Yang, Ailing
Chen, Xiangmei
Puig, Oscar
Yue, Yangbo
Shen, Zhirong
P1239: BRUTON TYROSINE KINASE (BTK) PROTEIN DEGRADER BGB-16673 IS LESS APT TO CAUSE, AND ABLE TO OVERCOME VARIABLE BTK RESISTANCE MUTATIONS COMPARED TO OTHER BTK INHIBITORS (BTKI)
title P1239: BRUTON TYROSINE KINASE (BTK) PROTEIN DEGRADER BGB-16673 IS LESS APT TO CAUSE, AND ABLE TO OVERCOME VARIABLE BTK RESISTANCE MUTATIONS COMPARED TO OTHER BTK INHIBITORS (BTKI)
title_full P1239: BRUTON TYROSINE KINASE (BTK) PROTEIN DEGRADER BGB-16673 IS LESS APT TO CAUSE, AND ABLE TO OVERCOME VARIABLE BTK RESISTANCE MUTATIONS COMPARED TO OTHER BTK INHIBITORS (BTKI)
title_fullStr P1239: BRUTON TYROSINE KINASE (BTK) PROTEIN DEGRADER BGB-16673 IS LESS APT TO CAUSE, AND ABLE TO OVERCOME VARIABLE BTK RESISTANCE MUTATIONS COMPARED TO OTHER BTK INHIBITORS (BTKI)
title_full_unstemmed P1239: BRUTON TYROSINE KINASE (BTK) PROTEIN DEGRADER BGB-16673 IS LESS APT TO CAUSE, AND ABLE TO OVERCOME VARIABLE BTK RESISTANCE MUTATIONS COMPARED TO OTHER BTK INHIBITORS (BTKI)
title_short P1239: BRUTON TYROSINE KINASE (BTK) PROTEIN DEGRADER BGB-16673 IS LESS APT TO CAUSE, AND ABLE TO OVERCOME VARIABLE BTK RESISTANCE MUTATIONS COMPARED TO OTHER BTK INHIBITORS (BTKI)
title_sort p1239: bruton tyrosine kinase (btk) protein degrader bgb-16673 is less apt to cause, and able to overcome variable btk resistance mutations compared to other btk inhibitors (btki)
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431179/
http://dx.doi.org/10.1097/01.HS9.0000971848.36885.5c
work_keys_str_mv AT fengxiaoyu p1239brutontyrosinekinasebtkproteindegraderbgb16673islessapttocauseandabletoovercomevariablebtkresistancemutationscomparedtootherbtkinhibitorsbtki
AT wangyangyang p1239brutontyrosinekinasebtkproteindegraderbgb16673islessapttocauseandabletoovercomevariablebtkresistancemutationscomparedtootherbtkinhibitorsbtki
AT longtao p1239brutontyrosinekinasebtkproteindegraderbgb16673islessapttocauseandabletoovercomevariablebtkresistancemutationscomparedtootherbtkinhibitorsbtki
AT bailanyue p1239brutontyrosinekinasebtkproteindegraderbgb16673islessapttocauseandabletoovercomevariablebtkresistancemutationscomparedtootherbtkinhibitorsbtki
AT yangxiaojiao p1239brutontyrosinekinasebtkproteindegraderbgb16673islessapttocauseandabletoovercomevariablebtkresistancemutationscomparedtootherbtkinhibitorsbtki
AT yangailing p1239brutontyrosinekinasebtkproteindegraderbgb16673islessapttocauseandabletoovercomevariablebtkresistancemutationscomparedtootherbtkinhibitorsbtki
AT chenxiangmei p1239brutontyrosinekinasebtkproteindegraderbgb16673islessapttocauseandabletoovercomevariablebtkresistancemutationscomparedtootherbtkinhibitorsbtki
AT puigoscar p1239brutontyrosinekinasebtkproteindegraderbgb16673islessapttocauseandabletoovercomevariablebtkresistancemutationscomparedtootherbtkinhibitorsbtki
AT yueyangbo p1239brutontyrosinekinasebtkproteindegraderbgb16673islessapttocauseandabletoovercomevariablebtkresistancemutationscomparedtootherbtkinhibitorsbtki
AT shenzhirong p1239brutontyrosinekinasebtkproteindegraderbgb16673islessapttocauseandabletoovercomevariablebtkresistancemutationscomparedtootherbtkinhibitorsbtki